click below
click below
Normal Size Small Size show me how
BS2014 - drugs
All the drugs from the BS2014 module at the University of Leicester
| Drug | Disorder/mechanism of action |
|---|---|
| Aspirin, paracetamol, ibuprofen, etc | Pain - inhibit cox enzymes from converting arachidonic acid to prostaglandins |
| Diazepam | Anxiety, insomnia - GABAa receptor agonist (sustained) |
| Alprazolam | Anxiety, insomnia - GABAa receptor agonist (sustained) |
| Chlordiazepoxide | Anxiety, insomnia - GABAa receptor agonist (sustained) |
| Clobazam | Anxiety, insomnia - GABAa receptor agonist (sustained) |
| Lorazepam | Anxiety, insomnia - GABAa receptor agonist (short acting) |
| Oxazepam | Anxiety, insomnia - GABAa receptor agonist (short acting) |
| Buspirone | Anxiety - serotonin receptor agonist |
| Propranolol | Anxiety - beta-blocker |
| Oxprenolol | Anxiety - beta-blocker |
| Phenytoin | Epilepsy - use dependent block of sodium channels |
| Carbamazepine | Epilepsy - use dependent block of sodium channels |
| Phenobarbital | Epilepsy - GABAa receptor agonist |
| Primidone | Epilepsy - GABAa receptor agonist |
| Vigabatrin | Epilepsy - inhibits GABA aminotransferase, and hence GABA breakdown |
| Clomipramine | Depression - inhibit noradrenaline and serotonin reuptake (tricyclic antidepressants) |
| Doxepin | Depression - inhibit noradrenaline and serotonin reuptake (tricyclic antidepressants) |
| Trimipramine | Depression - inhibit noradrenaline and serotonin reuptake (tricyclic antidepressants) |
| Imipramine | Depression - inhibit noradrenaline and serotonin reuptake (tricyclic antidepressants) |
| Lofepramine | Depression - inhibit noradrenaline and serotonin reuptake (tricyclic antidepressants) |
| Nortriptyline | Depression - inhibit noradrenaline and serotonin reuptake (tricyclic antidepressants) |
| Citalopram | Depression - selective serotonin re-uptake inhibitor (SSRI) |
| Escitalopram | Depression - selective serotonin re-uptake inhibitor (SSRI) |
| Fluoxetine | Depression - selective serotonin re-uptake inhibitor (SSRI) |
| Fluvoxamine | Depression - selective serotonin re-uptake inhibitor (SSRI) |
| Paroxetine | Depression - selective serotonin re-uptake inhibitor (SSRI) |
| Sertraline | Depression - selective serotonin re-uptake inhibitor (SSRI) |
| Duloxetine | Depression - serotonin - noradrenaline(norepinephrine) re-uptake inhibitor (SNRI) |
| Venlafaxine | Depression - serotonin - noradrenaline(norepinephrine) re-uptake inhibitor (SNRI) |
| Phenelzine | Depression - irreversible MAO inhibitor |
| Isocarboxazid | Depression - irreversible MAO inhibitor |
| Tranylcypromine | Depression - irreversible MAO inhibitor |
| Moclobemide | Depression - reversible MAO inhibitor |
| Mirtrazapine | Depression - alpha2-adrenoceptor antagonist |
| Lithium carbonate | Manic depression/bipolar disorder - uncompetitively inhibits inositol monophosphatase |
| Lithium citrate | Manic depression/bipolar disorder - uncompetitively inhibits inositol monophosphatase |
| Amphetamine | Narcolepsy, ADHD - taken up by noradrenaline uptake 1, packaged into vesicles, inhibits MAO, acts weakly on adrenoceptors (also used recreationally) |
| Cocaine | Mostly used recreationally, also used as a local anaesthetic - blocks re-uptake of noradrenaline, dopamine and serotonin |
| Chlorpromazine | Psychosis - D2 receptor antagonist |
| Levomepromazine | Psychosis - D2 receptor antagonist |
| Pericyazine | Psychosis - D2 receptor antagonist |
| Pipotiazine | Psychosis - D2 receptor antagonist |
| Fluphenazine | Psychosis - D2 receptor antagonist |
| Perphenazine | Psychosis - D2 receptor antagonist |
| Prochlorperazine | Psychosis - D2 receptor antagonist |
| Trifluoperazine | Psychosis - D2 receptor antagonist |
| Clozapine | Psychosis - D2 receptor antagonist |
| Olanzapine | Psychosis - D2 receptor antagonist |
| Phencyclidine | Mostly recreational - NMDA receptor blocker (aka "angel dust") |
| Ketamine | Mostly recreational - NMDA receptor blocker |
| Morphine | Pain - agonist for opioid receptors, particularly mu receptor |
| Heroin | Mostly recreational - opioid receptor agonist, particularly mu receptor |
| Naloxone | Heroin overdose - high affinity competitive mu opioid receptor antagonist |
| Buprenorphine | Heroin addiction - partial mu opioid receptor antagonist |
| L-DOPA | Parkinson's disease - increases rate of dopamine synthesis by replacing DOPA |
| Carbidopa | Parkinson's disease (used to optimise L-DOPA treatment) - inhibits peripheral DOPA decarboxylase |
| Benserazide | Parkinson's disease (used to optimise L-DOPA treatment) - inhibits peripheral DOPA decarboxylase |
| Selegiline | Parkinson's disease (used to optimise L-DOPA treatment) - inhibits MAO-B |
| Entacapone | Parkinson's disease (used to optimise L-DOPA treatment) - inhibits COMT |
| Domperidone | Parkinson's disease (used to optimise L-DOPA treatment) - blocks peripheral dopamine receptors |
| Bromocriptine | Parkinson's disease - dopamine receptor agonist |
| Lisuride | Parkinson's disease - dopamine receptor agonist |
| Pergolide | Parkinson's disease - dopamine receptor agonist |